FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/11/077048 [Registered on: 19/11/2024] Trial Registered Prospectively
Last Modified On: 12/11/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A Clinical Trial to Study the Effectiveness of Erand Leaf Alkaline Extract in the Management of Urinary Tract Infection and Painful Urination 
Scientific Title of Study   Randomised Controlled Clinical Study to Evaluate the Efficacy of Eranda Patra Kshara in the Management of Mutrakrucchra with Special Reference to Urinary Tract Infection 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shubham Shahaji Borse 
Designation  PG Scholar 
Affiliation  LRP Ayurvedic Medical College And Hospital Post Graduate Institute And Research Centre Islampur 
Address  LRP Ayurvedic Medical College And Hospital Post Graduate Institute And Research Centre Islampur Department of Shalyatantra Division No 1 Room No 1 Tal Walwa Dist Sangli MAHARASHTRA 415409 India

Sangli
MAHARASHTRA
415409
India 
Phone  9922953663  
Fax    
Email  shubhborse7@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Amit Ramachandra Shedge 
Designation  HOD Professor in Shalyatantra Department 
Affiliation  LRP Ayurvedic Medical College And Hospital Post Graduate Institute And Research Centre Islampur 
Address  LRP Ayurvedic Medical College And Hospital Post Graduate Institute And Research Centre Islampur Department of Shalyatantra Division No 1 Room No 1 Tal Walwa Dist Sangli MAHARASHTRA 415409 India

Sangli
MAHARASHTRA
415409
India 
Phone  8888944733  
Fax    
Email  amit.shedage12@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shubham Shahaji Borse 
Designation  PG Scholar 
Affiliation  LRP Ayurvedic Medical College And Hospital Post Graduate Institute And Research Centre Islampur 
Address  LRP Ayurvedic Medical College And Hospital Post Graduate Institute And Research Centre Islampur Department of Shalyatantra Division No 1 Room No 1 Tal Walwa Dist Sangli MAHARASHTRA 415409 India

Sangli
MAHARASHTRA
415409
India 
Phone  9922953663  
Fax    
Email  shubhborse7@gmail.com  
 
Source of Monetary or Material Support  
LRP Ayurvedic Medical College And Hospital PG Institute And Research Centre Urun Islampur Tal Walawa District Sangli 415409 Maharashtra India 
 
Primary Sponsor  
Name  Dr Shubham Shahaji Borse 
Address  Department Of Shalyatantra LRP Ayurvedic Medical College And Hospital PG Institute And Research Centre Urun Islampur Tal Walawa District Sangli 415409 Maharashtra India 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shubham Shahaji Borse  LRP Ayurvedic Medical College And Hospital Post Graduate Institute And Research Centre  Department of Shalyatantra Division No 1 Room No 1 LRP Ayurvedic Medical College And Hospital Post Graduate Institute And Research Centre Islampur Tal Walwa Dist Sangli 415409
Sangli
MAHARASHTRA 
9922953663

shubhborse7@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
LRP Ayurvedic Medical College And Hospital Post Graduate Institute And Research Centre Islampur  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N00-N99||Diseases of the genitourinary system. Ayurveda Condition: MUTRAKRUCCRAM, (2) ICD-10 Condition:N00-N99||Diseases of the genitourinary system. Ayurveda Condition: MUTRAKRUCCRAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Yavakshara, Reference: धन्वन्तरिनिघण्टु - २ शतपुष्पादिवर्ग, Route: Oral, Dosage Form: Kshara , Dose: 250(mg), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 15 Days, anupAna/sahapAna: Yes(details: Water), Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Eranda Patra Kshara, Reference: भा.प्र.नि.६४, Route: Oral, Dosage Form: Kshara , Dose: 250(mg), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 15 Days, anupAna/sahapAna: Yes(details: Water ), Additional Information:
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Patients having sign and symptoms of Mutrakruchra (Sadaha, Saruja Mutrapravruti) etc.
2.The age group between 18 to 60 years.
3.Patients irrespective of religion, sex and socioeconomic status.
 
 
ExclusionCriteria 
Details  1.Pregnancy & lactation.
2.Prostate enlargement.
3.Patients who having known case of any part of urinary tract, Renal failure, chronic kidney diseases, Renal calculus, Nephritis, Pyelonephritis.
4.Phimosis or paraphimosis.
5.Patients having known case of systemic illness like DM, HTN, Asthma, HIV, HbsAg.
6.Patients who having autoimmune disorders.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Decrease in Sign and Symptoms of jwar, Sadah mutrata, Sarakta mutrata, Saruja mutrata due to Urinary Tract Infection.  15 days 
 
Secondary Outcome  
Outcome  TimePoints 
Significant Decrease in Sign and Symptoms of Kruchra mutrata, Sadah mutrata, Muhurmuhur mutrata, Puya mutrata due to Urinary Tract Infection.  15 days 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   26/11/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Objective: To study the efficacy of Eranda-Patra Kshara is Effective in the Management of Mutrakrucchra with Special Reference to Urinary Tract Infection.

Group A: Eranda-Patra Kshara.

Group B: Yavakshara.

Appropriate Sampling Technique: Simple randomised sampling method by computerised random technique will be done for 80 patients of age group 18 to 60 years. 

The subjects will be randomised in two study groups i.e., Group A and B. The time and date of recruitment shall also be recorded in the enrolment log.

Follow up: 10th, 15th day.

Assessment Criteria: The study will be strictly based on assessment of subjective parameter by the grading them.

The data obtained will be analyzed statistically.

Observation and Results: Observation and results will be drawn according to assessment criteria.

Discussion: The observed phenomena will be discussed.

Conclusion: Conclusion will be drawn strictly on basis of statistical analysis and will be unbiased

Summary: The research study will be summarized in brief. 

Ethical Consideration: The study will be conducted in accordance with ethical guidelines and inform consent from participant. 
Close